Redundant roles for cJun-N-terminal kinase 1 and 2 in interleukin-1β-mediated reduction and modification of murine hepatic nuclear retinoid X receptor α

Journal of Hepatology

Volumn 51, Issue 5, 2009, Pages 898-908

  Kosters, Astrid ^a   White, Damara D ^a   Sun, Hongdan ^a   Thevananther, Sundararajah ^a   Karpen, Saul J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

IL 1 ; Inflammation; JNK; Liver; RXR

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 9; PROTEASOME; RETINOID X RECEPTOR ALPHA; STRESS ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION; INFLAMMATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL NUCLEUS; CELLS, CULTURED; GENE EXPRESSION; HEPATOCYTES; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; PHOSPHORYLATION; RETINOID X RECEPTOR ALPHA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349741297     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.06.029     Document Type: Article

References (57)

1. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
2. Geier A., Fickert P., and Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 3 (2006) 574-585
3. Schwabe R.F., Seki E., and Brenner D.A. Toll-like receptor signaling in the liver. Gastroenterology 130 (2006) 1886-1900
4. Migita K., Abiru S., Nakamura M., Komori A., Yoshida Y., Yokoyama T., et al. Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro. FEBS Lett 569 (2004) 235-239
5. Liu S., Gallo D.J., Green A.M., Williams D.L., Gong X., Shapiro R.A., et al. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70 (2002) 3433-3442
6. Ghose R., Zimmerman T.L., Thevananther S., and Karpen S.J. Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2 (2004) 4
7. Trauner M., Arrese M., Lee H., Boyer J.L., and Karpen S.J. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest 101 (1998) 2092-2100
8. Li D., Zimmerman T.L., Thevananther S., Lee H.Y., Kurie J.M., and Karpen S.J. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent. J Biol Chem 277 (2002) 31416-31422
9. Ghose R., Mulder J., von Furstenberg R.J., Thevananther S., Kuipers F., and Karpen S.J. Rosiglitazone attenuates suppression of RXRalpha-dependent gene expression in inflamed liver. J Hepatol 46 (2007) 115-123
10. Beigneux A.P., Moser A.H., Shigenaga J.K., Grunfeld C., and Feingold K.R. The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275 (2000) 16390-16399
11. Geier A., Dietrich C.G., Voigt S., Ananthanarayanan M., Lammert F., Schmitz A., et al. Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289 (2005) G831-G841
12. Kim M.S., Shigenaga J., Moser A., Feingold K., and Grunfeld C. Repression of farnesoid X receptor during the acute phase response. J Biol Chem 278 (2003) 8988-8995
13. Lickteig A.J., Slitt A.L., Arkan M.C., Karin M., and Cherrington N.J. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35 (2007) 402-409
14. Teng S., and Piquette-Miller M. The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312 (2005) 841-848
15. Zimmerman T.L., Thevananther S., Ghose R., Burns A.R., and Karpen S.J. Nuclear export of retinoid X receptor alpha in response to interleukin-1beta-mediated cell signaling: roles for JNK and SER260. J Biol Chem 281 (2006) 15434-15440
16. Geier A., Wagner M., Dietrich C.G., and Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta 1773 (2007) 283-308
17. Kosters A., and Karpen S.J. Bile acid transporters in health and disease. Xenobiotica 38 (2008) 1043-1071
18. Schwabe R.F., and Brenner D.A. Mechanisms of liver injury. I. TNFalpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290 (2006) G583-G589
19. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
20. Dong C., Yang D.D., Wysk M., Whitmarsh A.J., Davis R.J., and Flavell R.A. Defective T cell differentiation in the absence of Jnk1. Science 282 (1998) 2092-2095
21. Yang D.D., Conze D., Whitmarsh A.J., Barrett T., Davis R.J., Rincon M., et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9 (1998) 575-585
22. Sabapathy K., Jochum W., Hochedlinger K., Chang L., Karin M., and Wagner E.F. Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89 (1999) 115-124
23. Conze D., Krahl T., Kennedy N., Weiss L., Lumsden J., Hess P., et al. C-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J Exp Med 195 (2002) 811-823
24. Jaeschke A., Rincon M., Doran B., Reilly J., Neuberg D., Greiner D.L., et al. Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes. Proc Natl Acad Sci USA 102 (2005) 6931-6935
25. She Q.B., Chen N., Bode A.M., Flavell R.A., and Dong Z. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 62 (2002) 1343-1348
26. Qiao L., Han S.I., Fang Y., Park J.S., Gupta S., Gilfor D., et al. Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol Cell Biol 23 (2003) 3052-3066
27. Czaja M.J. Cell signaling in oxidative stress-induced liver injury. Semin Liver Dis 27 (2007) 378-389
28. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
29. Dong C., Yang D.D., Tournier C., Whitmarsh A.J., Xu J., Davis R.J., et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405 (2000) 91-94
30. Arbour N., Naniche D., Homann D., Davis R.J., Flavell R.A., and Oldstone M.B. C-Jun NH(2)-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8(+) T cell-mediated antiviral immunity. J Exp Med 195 (2002) 801-810
31. Sabapathy K., Hu Y., Kallunki T., Schreiber M., David J.P., Jochum W., et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr Biol 9 (1999) 116-125
32. Schattenberg J.M., Singh R., Wang Y., Lefkowitch J.H., Rigoli R.M., Scherer P.E., et al. JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43 (2006) 163-172
33. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
34. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 181 (1997) 257-266
35. Ruminy P., Gangneux C., Claeyssens S., Scotte M., Daveau M., and Salier J.P. Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm Res 50 (2001) 383-390
36. Shulman A.I., and Mangelsdorf D.J. Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353 (2005) 604-615
37. Karpen S.J. Nuclear receptor regulation of hepatic function. J Hepatol 36 (2002) 832-850
38. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., and Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16 (2002) 2382-2392
39. Berry M.N., and Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43 (1969) 506-520
40. Denson L.A., Sturm E., Echevarria W., Zimmerman T.L., Makishima M., Mangelsdorf D.J., et al. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121 (2001) 140-147
41. Geier A., Dietrich C.G., Voigt S., Kim S.K., Gerloff T., Kullak-Ublick G.A., et al. Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38 (2003) 345-354
42. Luster M.I., Germolec D.R., Yoshida T., Kayama F., and Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19 (1994) 480-488
43. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3 (2004) 950-964
44. Zollner G., Marschall H.U., Wagner M., and Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3 (2006) 231-251
45. Kim M.S., Sweeney T.R., Shigenaga J.K., Chui L.G., Moser A., Grunfeld C., et al. Tumor necrosis factor and interleukin 1 decrease RXRalpha, PPARalpha, PPARgamma, LXRalpha, and the coactivators SRC-1, PGC-1alpha, and PGC-1beta in liver cells. Metabolism 56 (2007) 267-279
46. Green R.M., Beier D., and Gollan J.L. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. Gastroenterology 111 (1996) 193-198
47. Hartmann G., Cheung A.K., and Piquette-Miller M. Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303 (2002) 273-281
48. Hartmann G., Kim H., and Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1 (2001) 189-199
49. Solomon C., White J.H., and Kremer R. Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha. J Clin Invest 103 (1999) 1729-1735
50. Macoritto M., Nguyen-Yamamoto L., Huang D.C., Samuel S., Yang X.F., Wang T.T., et al. Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands. J Biol Chem 283 (2008) 4943-4956
51. Adam-Stitah S., Penna L., Chambon P., and Rochette-Egly C. Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. J Biol Chem 274 (1999) 18932-18941
52. Lee H.Y., Suh Y.A., Robinson M.J., Clifford J.L., Hong W.K., Woodgett J.R., et al. Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem 275 (2000) 32193-32199
53. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98 (2001) 13681-13686
54. Bruck N., Bastien J., Bour G., Tarrade A., Plassat J.L., Bauer A., et al. Phosphorylation of the retinoid X receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity. Cell Signal 17 (2005) 1229-1239
55. Srinivas H., Juroske D.M., Kalyankrishna S., Cody D.D., Price R.E., Xu X.C., et al. C-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha. Mol Cell Biol 25 (2005) 1054-1069
56. Liu B., Wu J.F., Zhan Y.Y., Chen H.Z., Zhang X.Y., and Wu Q. Regulation of the orphan receptor TR3 nuclear functions by c-Jun N terminal kinase phosphorylation. Endocrinology 148 (2007) 34-44
57. Gao M., Labuda T., Xia Y., Gallagher E., Fang D., Liu Y.C., et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306 (2004) 271-275